Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Areena Swarup (NPI 1508857301)

Field	Value
Entity Type	Individual
Organization	Areena Swarup
Address	2152 S Vineyard Ste 129
City	Mesa
State	AZ
ZIP	85210
Taxonomy	Rheumatology Physician
NPI Enumerated	October 31, 2005

Payer Source	Total Paid
Medicare	$3.6M
Medicaid	$0

Key Findings

This provider reports $3.6M in lifetime Medicare revenue and has no Medicaid billing on file, indicating an effectively single-payer Medicare practice profile rather than a dual-payer mix. The absence of any Medicaid claims (listed as "none" in the record) means state Medicaid patterns are not available for comparative analysis.

Revenue is highly concentrated in a small set of high-cost injectable drugs: the precomputed top-three Medicare codes account for 57.8% of this provider's total Medicare revenue, with J3262 reported at $863.8K (23.8%), J1602 at $714K (19.7%), and J0129 at $523.1K (14.4%). Those three biologic/injectable products are the core revenue drivers of the practice and dominate Medicare receipts.

The code mix is consistent with a rheumatology practice that delivers on-site biologic infusions and injections: high-revenue J-codes such as J3262, J1602, J0129, J0897 and J3111 are central to the portfolio, and the presence of injection- and infusion-administration codes (96413, 96401, 96415) alongside outpatient E/M codes supports an operation with significant in-office infusion capacity. Routine labs and imaging codes (80053, 77085, 86140, 82306) further indicate ambulatory management of chronic rheumatologic conditions and monitoring of therapy.

Operational throughput appears substantial: 96413 is ranked #66 of 7514 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code) and 96401 and 96415 are also well above typical volumes, implying frequent multi-hour infusion encounters. High-volume office visit coding — 99214 at 1.7K claims, $151.7K (4.2%) and ranked #2502 of 479517 providers nationally (99th percentile; extreme outlier) — suggests a large established outpatient panel that supports the infusion workload.

Competitive standing varies by code: for J3262 the provider ranks #7 of 618 (99th percentile; extreme outlier, far above typical national volume for this code), indicating a nationally dominant volume position for tocilizumab administration, while J1602 is #20 of 1041 (98th percentile; notably above typical national volume), marking it as another clear high-volume specialty line. By contrast, J0129 ranks #218 of 1221 (82th percentile; typical, unremarkable volume), so not all biologics show exceptional relative volume.

Multiple individual codes are flagged as statistical outliers in national comparisons, which highlights the practice’s concentrated exposure to high-cost therapies: J3262 is described as an "extreme outlier," J1602 as "notably above typical," and other items such as 96413 and 99214 are likewise labeled "extreme outlier." These outlier labels indicate the provider operates at volumes for certain services that are well above typical national peer activity and warrant focused review of utilization patterns by payers.

The provider’s NPI was enumerated on 2005-10-31 (~21 years ago), indicating long tenure in the market; that duration is consistent with an established referral base and sustained service lines that could explain built-up infusion volumes and repeat biologic prescribing. Longitudinal presence increases the likelihood that current patterns reflect stable operational strategy rather than a short-term spike.

For payers and network managers, the single-payer Medicare scale and concentration in buy-and-bill biologic J-codes present clear contracting and utilization-management touchpoints: the practice’s heavy reliance on high-cost injectable drugs and frequent infusion/administration codes suggests opportunities to review site-of-care economics, infusion protocols, and drug acquisition/coverage arrangements while recognizing the provider’s unusually high national rank on several specific codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

64 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3262	Injection, tocilizumab, 1 mg	172,760	$10	$863.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	64,910	$10	$714K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	15,850	$30	$523K
J0897	Injection, denosumab, 1 mg	21,720	$20	$391K
J3111	Injection, romosozumab-aqqg, 1 mg	38,220	$10	$305.8K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	57,600	$1	$230.4K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,210	$30	$161.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,690	$90	$151.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,050	$100	$103.7K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	820	$50	$43.5K

Showing 1–10 of 64

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 64 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Areena Swarup — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

64 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	12	30	14,700	$30	$494.5K
J3262	1	20	74,500	$1	$367.2K
J1602	2	30	24,040	$10	$316.2K
J0717	7	20	36,100	$1	$246.6K
J3111	8	40	19,530	$10	$178.8K
J0897	16	260	2,940	$20	$115.6K
J1745	5	40	2,980	$30	$103.9K
86235	8	20	130	$20	$59.5K
86480	8	20	110	$60	$27.2K
86635	7	20	290	$10	$25.8K

Showing 1–10 of 64

Related Providers

Other providers that share a Tax Identification Number (TIN) with Areena Swarup, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Arizona Arthritis & Rheumatology Associates P C	AZ	Rheumatology Physician	$0	$11.2M
Nehad Soloman	AZ	Rheumatology Physician	$5.1M	$0
Alexander Hu	AZ	Internal Medicine Physician	$3.8M	$0
Saima Chohan	AZ	Rheumatology Physician	$3.5M	$0
Nikila Kumar	AZ	Rheumatology Physician	$3M	$0
John Tesser	AZ	Rheumatology Physician	$3M	$0
Daniel Kreutz	AZ	Rheumatology Physician	$2.8M	$0
Mona Amin	AZ	Rheumatology Physician	$2.7M	$0
Joonhee Lim	AZ	Rheumatology Physician	$2.3M	$0
Andrew Sharobeem	AZ	Rheumatology Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Areena Swarup, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Guthrie Mainstream Services LLC	AZ	Private Vehicle	$0	$81.8M
Nationwide Vision Center, LLC	AZ	Optician	$0	$42.6M
Rescare Residential Services Arizona, LLC	AZ	Child Intellectual and/or Developmental Disabilities Respite Care	$0	$17.4M
Eclipse Psychiatry Outpatient Treatment Center PLLC	AZ	Community/Behavioral Health Agency	$0	$15.9M
Heritage Life Center LLC	AZ	Assisted Living Facility (Mental Illness)	$0	$12M
Harmony Family Services LLC	AZ	Mental Health Counselor	$0	$11.9M
American Behavioral Solutions	AZ	Behavior Analyst	$0	$11.9M
Demo Community Services, LLC	AZ	Community/Behavioral Health Agency	$0	$11M
Milestone Pediatrics LLC	AZ	Speech-Language Pathologist	$0	$10.1M
Crossroads, Inc. Red Mountain	AZ	Substance Abuse Rehabilitation Facility	$0	$9.4M

Areena Swarup — Billing Profile & Reimbursement Data

Sign up for Areena Swarup — Billing Profile & Reimbursement Data policy alerts

Areena Swarup — Billing Profile & Reimbursement Data

Sign up for Areena Swarup — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References